Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Spectral AI, Inc. (MDAI : NSDQ)

• Company Description    Spectral MD Holdings Ltd. is a predictive AI company focused on medical diagnostics. The Company's DeepView(R) platform is a predictive diagnostic device which offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. Spectral MD Holdings Ltd., formerly known as ROSECLIFF ACQ, is based in DALLAS. Number of Employees: 78

• Price / Volume Information    Yesterday's Closing Price: $2.86 Daily Weekly Monthly 20 Day Moving Average: 650,803 shares Shares Outstanding: 25.32 (millions) Market Capitalization: $72.41 (millions) Beta: 0.90 52 Week High: $3.25 52 Week Low: $0.82 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 45.18% 38.62% 12 Week 130.65% 94.64% Year To Date 1.06% -5.04%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2515 McKinney Avenue Suite 1000 - Dallas,TX 75201 USA ph: 972-499-4934 fax: - ir@spectral-ai.com http://www.spectral-ai.com

• General Corporate Information    Officers J. Michael DiMaio - Principal Executive Officer and Chairman Vincent Capone - Chief Financial Officer Richard Cotton - Director Martin Mellish - Director Deepak Sadagopan - Director Peer Information Spectral AI, Inc. (ABMD) Spectral AI, Inc. (DMDS) Spectral AI, Inc. (CPWY.) Spectral AI, Inc. (EQUR) Spectral AI, Inc. (ECIA) Spectral AI, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 84757T105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/11/25 Share - Related Items Shares Outstanding: 25.32 Most Recent Split Date: (:1) Beta: 0.90 Market Capitalization: $72.41 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.15 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 2.42 EPS Growth vs. Year Ago Period: 157.89% vs. Previous Quarter: 283.33% Sales Growth vs. Year Ago Period: 6.02% vs. Previous Quarter: -11.80% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - -11.37 12/31/24 - -58.48 Current Ratio 06/30/25 - - 03/31/25 - 1.41 12/31/24 - 0.57 Quick Ratio 06/30/25 - - 03/31/25 - 1.37 12/31/24 - 0.55 Operating Margin 06/30/25 - - 03/31/25 - -5.53 12/31/24 - -26.23 Net Margin 06/30/25 - - 03/31/25 - -30.75 12/31/24 - -51.77 Pre-Tax Margin 06/30/25 - - 03/31/25 - -29.68 12/31/24 - -50.86 Book Value 06/30/25 - - 03/31/25 - -0.06 12/31/24 - -0.32 Inventory Turnover 06/30/25 - - 03/31/25 - 41.90 12/31/24 - 47.86 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©